Amesite Announces NurseMagic™ Meets HIPAA Requirements for Individuals Users, in Addition to Enterprises
Amesite Inc. (NASDAQ: AMST) announced that its NurseMagic™ platform now meets HIPAA requirements for all users, both individual and enterprise. The platform enables healthcare providers to securely store and handle patient information through Business Associate Agreements (BAA).
NurseMagic™, launched in June 2024, has expanded to users across all 50 U.S. States and 21 countries, serving professionals in over 130 different healthcare roles. The platform allows users to integrate documentation with any electronic medical record (EMR) system, leveraging AI capabilities to improve efficiency.
The company reports positive traction in both B2B and B2C sales, with the healthcare software-as-a-service market projected to reach over $90 Billion by 2033 at nearly 11% CAGR.
Amesite Inc. (NASDAQ: AMST) ha annunciato che la sua piattaforma NurseMagic™ ora soddisfa i requisiti HIPAA per tutti gli utenti, sia individuali che aziendali. La piattaforma consente ai fornitori di assistenza sanitaria di conservare e gestire in modo sicuro le informazioni dei pazienti tramite Accordi di Collaborazione Aziendale (BAA).
Lanciata a giugno 2024, NurseMagic™ si è estesa a utenti in tutti i 50 Stati degli Stati Uniti e in 21 paesi, supportando professionisti in oltre 130 diversi ruoli sanitari. La piattaforma permette agli utenti di integrare la documentazione con qualsiasi sistema di cartelle cliniche elettroniche (EMR), sfruttando le capacità dell’IA per migliorare l’efficienza.
L’azienda segnala un riscontro positivo sia nelle vendite B2B che B2C, con il mercato del software sanitario come servizio che si prevede supererà i 90 miliardi di dollari entro il 2033, con un tasso di crescita annuo composto (CAGR) vicino all’11%.
Amesite Inc. (NASDAQ: AMST) anunció que su plataforma NurseMagic™ ahora cumple con los requisitos HIPAA para todos los usuarios, tanto individuales como empresariales. La plataforma permite a los proveedores de salud almacenar y manejar de forma segura la información de los pacientes mediante Acuerdos de Asociados Comerciales (BAA).
Lanzada en junio de 2024, NurseMagic™ se ha expandido a usuarios en los 50 estados de EE. UU. y en 21 países, atendiendo a profesionales en más de 130 roles diferentes en el sector salud. La plataforma permite integrar la documentación con cualquier sistema de registros médicos electrónicos (EMR), aprovechando las capacidades de IA para mejorar la eficiencia.
La empresa reporta una buena aceptación tanto en ventas B2B como B2C, con el mercado de software sanitario como servicio proyectado a superar los 90 mil millones de dólares para 2033, con una tasa de crecimiento anual compuesta (CAGR) cercana al 11%.
Amesite Inc. (NASDAQ: AMST)는 자사의 NurseMagic™ 플랫폼이 개인 및 기업 사용자 모두를 위한 HIPAA 요구사항을 충족한다고 발표했습니다. 이 플랫폼은 비즈니스 협력 계약서(BAA)를 통해 의료 제공자가 환자 정보를 안전하게 저장하고 관리할 수 있도록 지원합니다.
2024년 6월에 출시된 NurseMagic™는 미국 50개 주 전역과 21개국의 사용자로 확장되어 130개 이상의 다양한 의료 직종 전문가들에게 서비스를 제공하고 있습니다. 이 플랫폼은 AI 기능을 활용해 효율성을 높이며, 모든 전자 의료 기록(EMR) 시스템과 문서 통합을 지원합니다.
회사는 B2B 및 B2C 판매 모두에서 긍정적인 반응을 보고하고 있으며, 의료 소프트웨어 서비스 시장은 2033년까지 연평균 성장률(CAGR) 약 11%로 900억 달러를 넘어설 것으로 예상됩니다.
Amesite Inc. (NASDAQ : AMST) a annoncé que sa plateforme NurseMagic™ répond désormais aux exigences HIPAA pour tous les utilisateurs, qu’ils soient individuels ou entreprises. La plateforme permet aux prestataires de soins de santé de stocker et gérer en toute sécurité les informations des patients via des accords de partenariat commercial (BAA).
Lancée en juin 2024, NurseMagic™ s’est étendue à des utilisateurs dans les 50 États américains et 21 pays, desservant des professionnels dans plus de 130 rôles différents dans le secteur de la santé. La plateforme permet l’intégration de la documentation avec tout système de dossier médical électronique (EMR), en exploitant les capacités de l’IA pour améliorer l’efficacité.
L’entreprise rapporte un bon dynamisme tant dans les ventes B2B que B2C, le marché des logiciels de santé en tant que service devant dépasser les 90 milliards de dollars d’ici 2033, avec un taux de croissance annuel composé (CAGR) d’environ 11 %.
Amesite Inc. (NASDAQ: AMST) gab bekannt, dass seine NurseMagic™-Plattform nun für alle Nutzer, sowohl Einzelpersonen als auch Unternehmen, die HIPAA-Anforderungen erfüllt. Die Plattform ermöglicht es Gesundheitsdienstleistern, Patientendaten sicher über Business Associate Agreements (BAA) zu speichern und zu verwalten.
NurseMagic™, im Juni 2024 gestartet, ist inzwischen in allen 50 US-Bundesstaaten und in 21 Ländern verfügbar und unterstützt Fachkräfte in über 130 verschiedenen Gesundheitsberufen. Die Plattform erlaubt die Integration von Dokumentationen mit jedem elektronischen Gesundheitsakten-System (EMR) und nutzt KI-Funktionalitäten zur Effizienzsteigerung.
Das Unternehmen berichtet von positiver Resonanz im B2B- und B2C-Verkauf, wobei der Markt für Gesundheitssoftware als Service bis 2033 voraussichtlich über 90 Milliarden US-Dollar erreichen wird, bei einer jährlichen Wachstumsrate (CAGR) von fast 11 %.
- Platform now HIPAA-compliant for all users, expanding market reach
- Presence in all 50 U.S. states and 21 countries
- Growing B2B and B2C recurring revenue streams
- Integration capability with any EMR system
- None.
Insights
NurseMagic's HIPAA compliance for individuals expands addressable market, enabling growth in both enterprise and direct-to-provider channels.
The expansion of NurseMagic's HIPAA compliance from enterprise-only to include individual healthcare providers represents a strategic market expansion. By offering Business Associate Agreements (BAAs) to individual users, Amesite has removed a critical regulatory barrier that previously adoption to enterprise customers only.
This enhancement addresses a key workflow challenge in healthcare. Individual providers can now securely enter protected health information (PHI) into NurseMagic and transfer documentation to any electronic medical record system. This integration approach is particularly valuable in healthcare's fragmented IT ecosystem, where complete platform switching is often impractical.
The adoption across 130 different healthcare roles - including RNs, Nurse Practitioners, Paramedics, and Hospital Managers - demonstrates broad utility. The company launched NurseMagic in June 2024 and has rapidly expanded to users across all 50 U.S. states and 21 countries within its first year.
Amesite is targeting a healthcare SaaS market projected to reach
Expanded HIPAA compliance unlocks direct-to-provider market, potentially accelerating revenue growth for micro-cap Amesite's AI nurse assistant.
Amesite's expansion of HIPAA compliance to individual users creates a dual revenue stream opportunity for their NurseMagic product. The company previously reported increased B2B sales after achieving enterprise HIPAA compliance last year, suggesting this individual-focused enhancement could drive similar growth in the B2C channel.
This development effectively doubles NurseMagic's addressable market without requiring significant additional product development. For a micro-cap company with approximately
The recurring revenue model is particularly significant. NurseMagic operates as a subscription service, which typically generates more predictable and stable revenue than one-time purchases. Management explicitly mentioned "building recurring revenue" through both B2B and B2C sales channels.
While no specific revenue figures were provided, the company's rapid geographic expansion to all 50 states and 21 countries less than a year after launch demonstrates initial market acceptance. This healthcare-specific application leverages Amesite's existing AI expertise from their academic and business segments, allowing them to enter a specialized vertical market while utilizing their core technological capabilities.
NurseMagic™ Now Supports Healthcare Workers in Any Care Setting, Allowing Every Provider to Store Confidential Patient Information
DETROIT, April 22, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced NurseMagic™ now meets HIPAA requirements for all users. This extension ensures that all usage—individual or enterprise—meets regulatory standards for handling sensitive healthcare information. Amesite announced that it met HIPAA requirements for enterprises late last year, and subsequently reported increased sales in B2B.
To meet HIPAA requirements, care providers are required to execute a Business Associate Agreement (BAA) with their software vendors. NurseMagic™ now provides a BAA for all users, whether licenses are purchased by enterprises or by individuals. Any provider can confidently enter patient details or other personally identifiable health information (PHI) into NurseMagic™’s safe, secure environment. Users can copy and paste documentation produced with NurseMagic™ into any electronic medical record (EMR) system, enabling them to take advantage of NurseMagic™’s AI capabilities, no matter their current software infrastructure.
“Meeting HIPAA requirements for all of our users is a natural extension of what we’ve already provided to enterprise customers,” said Kalie Wortinger, Senior Manager of Engineering at Amesite. “We operate in a highly regulated industry, where protecting sensitive data is essential. This expansion reinforces our commitment to trust, privacy, and long-term value—for individual users, organizations, and their patients.”
“We believe that NurseMagic™'s usage by professionals in more than 130 different roles—from Registered Nurses and Nurse Practitioners to Paramedics, Medical Directors, and Hospital Managers—demonstrates the real-world impact of our solution in empowering healthcare workers to enhance care delivery, and meet diverse demands in the industry,” said Sai Nittala, Senior AI Manager at Amesite.
“We believe we have good traction in both B2B and B2C sales, growing our user base and building recurring revenue. As Amesite's AI tools are deployed across healthcare, we expect to lead the industry in reducing documentation burden and improving care team efficiency,” said Dr. Ann Marie Sastry, CEO of Amesite.
Amesite launched NurseMagic™ less than a year ago in June of 2024, leveraging its successes globally in academic and business segments, and quickly generated users across all 50 U.S. States and 21 countries. The app has garnered top reviews and testimonials. Amesite has since announced successful launches of Automated Enterprise Sales Flow, Enterprise Sales to Large Franchisees and Paid Consumer Subscriptions. The healthcare software-as-a-service market is expected to reach a revenue of over
For more information on NurseMagic™, visit www.nursemagic.ai
About Amesite
Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the
Forward-Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations
ir@amesite.com
FAQ
What are the key features of Amesite's NurseMagic™ HIPAA compliance update in 2025?
How widespread is the adoption of AMST's NurseMagic™ platform since its June 2024 launch?
What is the market potential for AMST's healthcare software solutions?
How does NurseMagic™ integrate with existing healthcare systems?
